Role of maspin in cancer by Rossana Berardi, Francesca Morgese, Azzurra Onofri, Paola Mazzanti, Mirco Pistelli, Zelmira Ballatore, Agnese Savini, Mariagrazia De Lisa, Miriam Caramanti, Silvia Rinaldi, Silvia Pagliaretta, Matteo Santoni, Chiara Pierantoni, Stefano Cascinu

“…Its expression is down‐regulated in breast, prostate, gastric and melanoma cancers but over‐expressed in pancreatic, gallbladder, colorectal, and thyroid cancers suggesting that maspin may play different activities in different cell types. …”
Get full text

A Population-Based Analysis of 30-Year Mortality among Five-Year Survivors of Adolescent and Young Adult Cancer: The Roles of Primary Cancer, Subsequent Malignancy, and Other Healt... by Diana J. Moke, Ziwei Song, Lihua Liu, Ann S. Hamilton, Dennis Deapen, David R. Freyer

“…At 30 years, cumulative mortality due to primary cancer was matched by that due to all other causes (12.8% 95% CI [12.5%, 13.0%] for primary cancer versus 12.8% [12.5%, 13.1%] for all other causes combined) in the combined cohort, and was overtaken by non-malignant conditions in Hodgkin lymphoma, testicular, cervical/uterine, and thyroid cancers. Overall, SMNs accounted for 20% of malignant deaths, the most common being lung/bronchus (25.6%), colorectal/liver/biliary/pancreas (19.1%), and breast (10.2%). …”
Get full text

Familial adenomatous polyposis, diagnosis and surveillance strategies: review article by Sima Sedighi, Maliheh Moradzadeh, Mehrdad Aghaei, Ashraf Mohamadkhani, Mohammad Hassan Jokar

“…Patients suffering from familial adenomatous polyposis have a range of extra-intestinal diseases such as papillae, gastric, small intestine, and duodenal polyps; cutaneous wounds (lipomas, fibromas, and epidermoid cysts); desmoid tumors; osteomas; nephroderma retinal pigment epithelium, including hepatoblastoma and thyroid cancers; and pancreas, biliary system, and brain cancer. …”
Get full text

Effect of Minimally Invasive Spine Stabilization in Metastatic Spinal Tumors by Kazuo Nakanishi, Kazuya Uchino, Seiya Watanabe, Kosuke Misaki, Hideaki Iba

“…Patients with breast, prostate, renal, and thyroid cancers had a good prognosis, whereas those with gastrointestinal and head and neck cancers had a poor prognosis. …”
Get full text

GLP-1(28-36)amide, the Glucagon-like peptide-1 metabolite: friend, foe, or pharmacological folly? by Taing MW, Rose FJ, Whitehead JP

“…Moreover, although controversial, concerns have been raised about the potential for incretin-based therapies to promote pancreatitis and pancreatic and thyroid cancers. The effects ascribed to the nonapeptide make it a potential contributor to such outcomes, raising additional questions about its therapeutic suitability. …”
Get full text

Amplicon-Based NGS Panels for Actionable Cancer Target Identification in Follicular Cell-Derived Thyroid Neoplasia by Majbritt Busk Madsen, Katalin Kiss, Finn Cilius Nielsen, Finn Noe Bennedbæk, Maria Rossing

“…Follicular cell-derived thyroid cancers are heterogenous and morphological classification is a complex and highly specialized task. …”
Get full text

The Roles of Beclin 1 Expression in Gastric Cancer: A Marker for Carcinogenesis, Aggressive Behaviors and Favorable Prognosis, and a Target of Gene Therapy by Hua-chuan Zheng, Shuang Zhao, Hang Xue, En-hong Zhao, Hua-mao Jiang, Chang-lai Hao

“…Becn1-related signal pathways in gastric cancer included prostate, lung, renal, colorectal, endometrial and thyroid cancers, glioma, and leukemia, the metabolism of amino acid, lipid and sugar, and some signal pathways of insulin, MAPK, TRL, VEGF, JAK-STAT, chemokine, p53, lysosome, peroxidome and ubiquitin-mediated protein degradation (P<0.05). …”
Get full text

Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study by Jinkui Wang, Chenghao Zhanghuang, Liming Jin, Zhaoxia Zhang, Xiaojun Tan, Tao Mi, Jiayan Liu, Mujie Li, Xin Wu, Xiaomao Tian, Dawei He

“…Papillary thyroid carcinoma (PTC) accounts for more than 80% of thyroid cancers. Accurate prediction of elderly PTC can help reduce the mortality of patients. …”
Get full text

Factors associated with health-related quality of life in a cohort of cancer survivors in New Jersey by Sharon Manne, Katie Devine, Shawna Hudson, Deborah Kashy, Denalee O’Malley, Lisa E. Paddock, Elisa V. Bandera, Adana A. M. Llanos, Angela Fong, Neetu Singh, Sara Frederick, Andrew M. Evens

“…Methods Eligible survivors were residents of New Jersey diagnosed with genitourinary, female breast, gynecologic, colorectal, lung, melanoma, or thyroid cancers. Participants completed measures of social determinants, health behaviors, survivorship care experiences, psychosocial factors, and HRQoL. …”
Get full text

Evaluations for Determination of Optimum Shields in Nuclear Medicine by R parvaresh, M Jalili, A Haghparast, K Khoshgard, M T Eivazi, M Ghorbani

“…Background: ¹³¹I source is widely used in the treatment of hyperthyroidism and thyroid cancers. ^{<span>131</span>}I emits both beta and gamma-rays. …”
Get full text

Trends in the burden of most common obesity‐related cancers in 16 Southern Africa development community countries, 1990–2019. Findings from the global burden of disease study by Philimon Gona, Clara Gona, Suha Ballout, Chabila Mapoma, Sowmya Rao, Ali Mokdad, (GBD 2019 SADC BMI)

“…A descriptive epidemiological analysis was conducted to assess the burden of obesity‐related cancers, (liver, esophageal, breast, prostate, colon/rectal, leukemia, ovarian, uterine, pancreatic, kidney, gallbladder/biliary tract, and thyroid cancers) in SADC countries. Methods Data from the 2019 Global Burden of Diseases Study was used. …”
Get full text

Local and Context-Attention Adaptive LCA-Net for Thyroid Nodule Segmentation in Ultrasound Images by Zhen Tao, Hua Dang, Yueting Shi, Weijiang Wang, Xiaohua Wang, Shiwei Ren

“…The thyroid nodule segmentation of ultrasound images is a critical step for the early diagnosis of thyroid cancers in clinics. Due to the weak edge of ultrasound images and the complexity of thyroid tissue structure, it is still challenging to accurately segment the delicate contour of thyroid nodules. …”
Get full text

Test evaluation trials present different challenges for trial managers compared to intervention trials by Caroline Rick, Sue Mallett, James Brown, Ryan Ottridge, Andrew Palmer, Victoria Parker, Lee Priest, Jonathan J. Deeks

“…The trials covered a range of medical conditions, diagnostic tests, clinical pathways and conditions including chronic kidney disease, chronic pelvic pain, colitis, detrusor over-activity, group B streptococcal colonisation, tuberculosis and colorectal, lung, ovarian and thyroid cancers. Results We identified 10 common themes underlying challenges that are more pronounced in test evaluation compared to intervention trials. …”
Get full text

Frequency of Thyroid Microcarcinoma in Patients Who Underwent Total Thyroidectomy with Benign Indication—A 5-Year Retrospective Review by Vasiliki Magra, Kassiani Boulogeorgou, Eleni Paschou, Christina Sevva, Vasiliki Manaki, Ioanna Mpotani, Stylianos Mantalovas, Styliani Laskou, Isaak Kesisoglou, Triantafyllia Koletsa, Konstantinos Sapalidis

“…<i>Background and Objectives</i>: Incidental thyroid cancers (ITCs) are often microcarcinomas. The most frequent histologic type is a papillary microcarcinoma. …”
Get full text

Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020 by Stefano Guzzinati, Saverio Virdone, Roberta De Angelis, Chiara Panato, Carlotta Buzzoni, Riccardo Capocaccia, Silvia Francisci, Anna Gigli, Manuel Zorzi, Giovanna Tagliabue, Diego Serraino, Fabio Falcini, Claudia Casella, Antonio Giampiero Russo, Fabrizio Stracci, Bianca Caruso, Maria Michiara, Anna Luisa Caiazzo, Marine Castaing, Stefano Ferretti, Lucia Mangone, Giuseppa Rudisi, Flavio Sensi, Guido Mazzoleni, Fabio Pannozzo, Rosario Tumino, Mario Fusco, Paolo Ricci, Gemma Gola, Adriano Giacomin, Francesco Tisano, Giuseppa Candela, Anna Clara Fanetti, Filomena Pala, Antonella Sutera Sardo, Massimo Rugge, Laura Botta, Luigino Dal Maso

“…The largest 10-year increases are foreseen for prostate (+ 85%) and for thyroid cancers (+ 79%), and for long-term survivors diagnosed since 20 or more years (+ 45%). …”
Get full text

Short-stay thyroid surgery for older patients, is it safe? by Kalezić Marko, Živić Rastko, Đukić Vladimir, Milanović Miljan, Ostojić Milkica, Rančić Nemanja, Vekić Berislav

“…The incidence of nodular thyroid dis-ease increases significantly with age as well as the incidence and aggressiveness of thyroid cancers. The aim of the study was to determine whether thyroid surgery for geriatric patients is safe in a short hospital stay surgery set-ting. …”
Get full text

Comparative Analysis of Computer-Aided Diagnosis and Computer-Assisted Subjective Assessment in Thyroid Ultrasound by Nonhlanhla Chambara, Shirley Yuk Wah Liu, Xina Lo, Michael Ying

“…Future larger multi-center and multi-rater prospective studies with a diverse representation of thyroid cancers are necessary to validate these findings.…”
Get full text

Preoperative prediction of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: a Canadian single-Centre experience by Vincent Larouche, Marc Philippe Pusztaszeri, Sabin Filimon, Richard Payne, Michael Hier, Michael Tamilia

“…Abstract Background An international group of experts recommended reclassifying non-invasive follicular variant of papillary thyroid cancers (FVPTC) as ‘non-invasive follicular thyroid neoplasm with papillary-like nuclear features’ (NIFTP) in April 2016. …”
Get full text

Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis by Rituraj Upadhyay, Divya Yadav, Bhanu P. Venkatesulu, Raj Singh, Sujith Baliga, Raju R. Raval, Margot A. Lazow, Margot A. Lazow, Ralph Salloum, Ralph Salloum, Maryam Fouladi, Maryam Fouladi, Elaine R. Mardis, Nicholas G. Zaorsky, Daniel M. Trifiletti, Arnold C. Paulino, Joshua D. Palmer

“…The most common SMN were gliomas (40.6%) followed by meningiomas (38.7%), sarcomas (4.8%), and thyroid cancers (4.2%). The median follow-up was 8.8 years [3.3–23.2].The median latency to SMN for photons and protons were 11.9 years [5-23] and 5.9 years [5-6.7], respectively. …”
Get full text

Rosacea and Its Association With Malignancy: Systematic Review by Luna Thapa, Joyce Xia, William Guo, Hunya Usmani, Devin Miller, Daniel Lozeau

“…The associations between rosacea and hepatic and thyroid cancers were unclear because of conflicting results. …”
Get full text